Cinqair IV Therapy in Columbia, MD: A Treatment Option for Severe Asthma

At Jean Walter Infusion Center, we provide advanced infusion therapies to help patients manage complex medical conditions. One such therapy is Cinqair (reslizumab) intravenous (IV) treatment, which is specially designed for adults with severe eosinophilic asthma—a form of asthma marked by high levels of eosinophils (a type of white blood cell that contributes to inflammation in the airways).

Many patients with severe eosinophilic asthma continue to experience frequent symptoms and flare-ups even while taking high-dose inhaled corticosteroids and other standard asthma medications. For these individuals, Cinqair serves as an important add-on maintenance therapy. It works by targeting interleukin-5, a key molecule that drives eosinophil activity, helping to reduce airway inflammation and improve asthma control.

At Jean Walter Infusion Center, our experienced clinical team works closely with referring physicians to provide safe and comfortable Cinqair IV infusions in a welcoming environment. We offer comprehensive monitoring and support throughout your treatment, ensuring you receive the best possible care while managing your severe asthma.

At Jean Walter Infusion Center, we are committed to providing advanced, personalized care for individuals with severe asthma. One of the innovative treatments we offer is Cinqair (reslizumab), an FDA-approved medication designed to help manage severe eosinophilic asthma—particularly in patients whose asthma is driven by high levels of a specific type of white blood cell called eosinophils.

In severe eosinophilic asthma, the immune system produces too many eosinophils, resulting in chronic inflammation and swelling in the airways. This can make breathing difficult and increase the risk of asthma attacks. Cinqair works by targeting a protein called interleukin-5 (IL-5), which is crucial for the growth and survival of eosinophils. By binding to IL-5, Cinqair reduces the number of eosinophils in the body, helping to decrease airway inflammation, reduce asthma symptoms, and lower the frequency of severe asthma attacks.

Cinqair is administered as an intravenous (IV) infusion by a healthcare professional, typically once every four weeks. At Jean Walter Infusion Center, our highly trained staff ensures that every infusion is delivered in a comfortable, supportive, and closely monitored environment. We work closely with your asthma specialist to tailor your treatment plan, monitor your progress, and provide comprehensive support throughout your therapy.

If your asthma is not well controlled with standard inhaled medications and you have been diagnosed with severe eosinophilic asthma, Cinqair may offer a more personalized approach to managing your condition. Our team at Jean Walter Infusion Center is here to answer your questions and help determine if Cinqair infusion therapy is right for you.

If you or a loved one is struggling with severe asthma that has not responded well to standard treatments, Jean Walter Infusion Center in Columbia, MD, offers advanced options such as Cinqair (reslizumab) infusion therapy. Cinqair is designed specifically for adults with severe eosinophilic asthma—a type of asthma linked to high levels of eosinophils, a white blood cell involved in airway inflammation.

At Jean Walter Infusion Center, our experienced healthcare team will carefully evaluate whether Cinqair is right for you. Eligibility typically involves:

• Diagnosis of Severe Eosinophilic Asthma: Patients must have a confirmed diagnosis, based on symptoms and elevated eosinophil counts from blood tests.

• Insufficient Control with Standard Therapies: Cinqair is intended for adults whose asthma remains uncontrolled despite high-dose inhaled corticosteroids and additional controller medications.

• Individualized Assessment: Our providers will thoroughly review your asthma history, current medications, and any other medical conditions or allergies before recommending Cinqair.

It’s important to note that Cinqair is not suitable for other types of asthma or for treating acute asthma attacks. The safety and effectiveness of Cinqair have not been established in children or adolescents.

At Jean Walter Infusion Center, we believe in a collaborative approach to care. Our team will work closely with you to determine if Cinqair infusion therapy aligns with your treatment goals and medical needs. If Cinqair is recommended, your infusion therapy will be administered in our comfortable, state-of-the-art facility by skilled professionals dedicated to your safety and well-being.

At Jean Walter Infusion Center, we offer Cinqair (reslizumab) intravenous therapy as part of our comprehensive care for patients with severe eosinophilic asthma. Cinqair is administered as an add-on maintenance treatment, delivered once every four weeks under the supervision of our experienced healthcare professionals.

During each appointment at our infusion center, your Cinqair dose will be carefully administered through an intravenous infusion, a process that typically takes 20 to 50 minutes. Receiving your infusions on a consistent monthly schedule at Jean Walter Infusion Center is essential for optimal asthma control.

Our medical team will work closely with your prescribing physician to monitor your response and adjust your treatment plan as needed, ensuring the therapy is tailored to your individual health status and needs.

Patients receiving regular Cinqair infusions at Jean Walter Infusion Center often experience a noticeable reduction in the frequency and intensity of asthma exacerbations. This can translate to fewer emergency room visits and hospital stays, allowing for a more active and fulfilling lifestyle. Many of our patients report improved breathing and greater participation in everyday activities, thanks to better symptom control.

Another significant advantage of Cinqair therapy is the potential reduction in the need for oral corticosteroids, which are commonly associated with adverse long-term side effects. By addressing the root cause of inflammation, Cinqair helps improve lung function and overall quality of life.

At Jean Walter Infusion Center, your safety and comfort are our top priorities. Dr. Nasseri, MD, and our experienced healthcare professionals provide infusions in a welcoming, state-of-the-art environment, ensuring you receive personalized attention at every visit. We closely monitor you during and after your infusion to promptly address any side effects and to support your ongoing well-being. 

Choosing Jean Walter Infusion Center means you’ll receive expert care tailored to your unique health needs, with a team committed to helping you achieve the best possible outcomes in your asthma management. For more information, contact us or book an appointment online. We are conveniently located at 5500 Knoll North Dr, Suite 250A, Columbia, MD 21045. We serve patients from Columbia, MD, Ellicott City MD, Laurel MD, Clarksville MD, Fulton MD, and surrounding areas.